SCHEMBL6159277

SCHEMBL6159277

COc1ccc(Cn2cc[nH]c2=O)c(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ APLNR P35414 1/20 0.49
▸ DBH P09172 1/20 0.47
▸ ALDH1A1 P00352 4/20 0.45
▸ MAPT P10636 2/20 0.45
▸ EGLN1 Q9GZT9 2/20 0.43
▸ CA2 P00918 3/20 0.43
▸ TSHR P16473 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ KDM4C Q9H3R0 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ PDE4B Q07343 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10628077 0.86 EGLN1 (0.47) APLNRDBHALDH1A1MAPTEGLN1
SCHEMBL27629672 0.81 CA1 (0.41) DBHALDH1A1CA2PDE4B
SCHEMBL23120458 0.80 APLNR (0.48) APLNRALDH1A1MAPTCA2TSHR
SCHEMBL6156795 0.78 CMA1 (0.53) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL27871199 0.76 MAPT (0.60) MAPTMEN1KMT2APOLB
SCHEMBL5259359 0.74 APLNR (0.48) APLNRALDH1A1MAPTEGLN1KDM4E
SCHEMBL9804694 0.72 KDM4E (0.61) APLNRALDH1A1MAPTTSHRKDM4E
SCHEMBL8175132 0.72 LMNA (0.56) APLNRALDH1A1MAPTEGLN1TSHR
SCHEMBL13486597 0.72 GSK3A (0.58) APLNRALDH1A1MAPTCA2TSHR
SCHEMBL8331084 0.71 LMNA (0.57) APLNRALDH1A1MAPTEGLN1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832071-B1 1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES HAVING PDE IV AND CYTOKININ INHIBITING ACTIVITY JANSSEN PHARMACEUTICA NV (BE) 2005-09-28 — — EP disclosed
US-5869515-A TREATING ASTHMATIC OR ATOPIC DISEASES JANSSEN PHARMACEUTICA N.V. (BE) 1999-02-09 — — US disclosed
Send feedback